Company page

Hemostemix Inc

Hemostemix Inc (Ticker: HEM) is a public company based in Canada, focused on developing innovative therapies for various medical conditions. With a market capitalization of approximately CAD 6.7 million, the company is engaged in advancing its research and product offerings in the healthcare sector. Hemostemix aims to address unmet medical needs through its unique approach to treatment.